RxDoctor Payments Data

Sarah Gough, NP

Women's Health · Dallas, TXNPI 1487089108

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 96.7% of the total across 235 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 31 manufacturers, the largest accounting for just 18.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,641 and has fallen 73.1% since, to $442 in 2025. Among women's health clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$5,248in general payments, 2019–2025

Across 235 payments — averaging $22.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$965
  • Mayne Pharma Commercial LLC$594
  • Astellas Pharma US Inc$437
  • Daiichi Sankyo Inc.$434
  • Exeltis, USA Inc.$432
  • Shield Therapeutics Inc$378
  • plus $2K from 25 others

What the payments were for

  • Food & beverage$5,07497%
  • Education$1743%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,248 in reported general payments places this provider in the 95th percentile of 609 women's health providers in Texas.

See all women's health providers in Texas

Medicare billing

Part B allowed, 2024
$12,339
Medicare patients
80
Services billed
269

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Estradiol53$1,839
Alendronate Sodium20$147
Metronidazole17$145
Fluconazole13$61

Paid to pharmacies, not to this prescriber.

Other women's health in Dallas

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →